FIVE vs GILD · P/E 28, rev $1.39B vs P/E 18, rev $29.44B
Five Below Inc (FIVE) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FIVE currently screens at market cap $7.30B and trailing P/E 27.7. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FIVE and GILD stock pages for the full models.
Not investment advice.